Cipla
CIPLA
Cipla Market Sentiment
| Timeline | Returns | Volume |
|---|---|---|
| Daily | 0.10% | 20,27,213 |
| Weekly | - | 30,01,647 |
| Monthly | -3.81% | 2,15,91,570 |
Cipla Performance
| Timeline | Daily | Weekly | Monthly |
|---|---|---|---|
| CIPLA | 0.10% | - | -3.81% |
| Index | -1.88% | - | 0.10% |
| Peer Avg. | 0.57% | - | 7.11% |
Cipla Fundamentals
| Timeline | PE | PB | EV/EBIDTA | ROE | ROCE | Div. Yield |
|---|---|---|---|---|---|---|
| CIPLA | 31.60 | 3.80 | 17.73 | 12.90 | 17.04 | 0.47 |
| Index | 35.44 | 5.98 | 16.81 | 16.99 | 18.41 | 1.19 |
| Peer Avg. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cipla Key Metrics
| Metrics | Sales Growth | Profit Growth | ROE | ROCE |
|---|---|---|---|---|
| FY '21-22 | 14.71% | 19.06% | 12.90 | 17.04 |
| FY '20-21 | 0.56% | 21.71% | 12.55 | 16.50 |
| FY '19-20 | 3.50% | 12.62% | 12.05 | 15.31 |
Cipla Shareholding Pattern
Cipla Profit & Loss
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| FY '21-22 | 17,427.56 | 13,488.35 | 4,433.43 | 2,624.43 |
| FY '20-21 | 15,231.15 | 11,573.12 | 3,908.05 | 2,222.97 |
| FY '19-20 | 14,895.57 | 11,961.98 | 3,575.16 | 1,932.58 |
Cipla Similar Stocks
Dr. Reddy's Laboratories
DRREDDY
Lupin
LUPIN
Torrent Pharmaceuticals
TORNTPHARM
Alembic
ALEMBICLTD
J.B. Chemicals & Pharmaceuticals
JBCHEPHARM
Sequent Scientific
SEQUENT
IOL Chem and Pharma
IOLCP
Aarti Drugs
AARTIDRUGS
Ipca Laboratories
IPCALAB
Sun Pharmaceutical Industries
SUNPHARMA
Hikal
HIKAL
Caplin Point Laboratories
CAPLIPOINT
Aurobindo Pharma
AUROPHARMA
NATCO Pharma
NATCOPHARM
Jubilant Pharmova
JUBLPHARMA
Shilpa Medicare
SHILPAMED
FDC
FDC
Glenmark Pharmaceuticals
GLENMARK
Wockhardt
WOCKPHARMA
Zydus Lifesciences
ZYDUSLIFE
Ajanta Pharmaceuticals
AJANTPHARM
Granules India
GRANULES
Divi's Laboratories
DIVISLAB
Biocon
BIOCON
Indoco Remedies
INDOCO
Alkem Laboratories
ALKEM
Eris Lifesciences
ERIS
Alembic Pharmaceuticals
APLLTD
Gland Pharma
GLAND
Laurus Labs
LAURUSLABS
Suven Pharmaceuticals
SUVENPHAR
AstraZenca Pharma India
ASTRAZEN
Cipla Share Price
Cipla Limited is an Indian company primarily engaged in the pharmaceutical business. The company's segments are Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and markets generic or branded generic drugs and active ingredients (APIs). The New Ventures segment includes corporate operations, consumer healthcare, biosimilar and specialty businesses. Its product portfolio includes complex generics and respiratory, antiretroviral, urology, cardiology, infectious and CNS medicines and CNS and CNS medicines. The company's geographic segments include India, the United States, South Africa and the rest of the world. The company has a network of manufacturing, trading and other incidental activities in India and international markets. The company has about 46 factories.